Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group
- PMID: 35320498
- PMCID: PMC9170630
- DOI: 10.1007/s11912-022-01213-3
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group
Abstract
Purpose of review: The present narrative systematic review summarizes current knowledge on germline gene mutations predisposing to solid tumors in adolescents and young adults (AYAs).
Recent findings: AYAs with cancer represent a particular group of patients with specific challenging characteristics and yet unmet needs. A significant percentage of AYA patients carry pathogenic or likely pathogenic variants (PV/LPVs) in cancer predisposition genes. Nevertheless, knowledge on spectrum, frequency, and clinical implications of germline variants in AYAs with solid tumors is limited. The identification of PV/LPV in AYA is especially critical given the need for appropriate communicative strategies, risk of second primary cancers, need for personalized long-term surveillance, potential reproductive implications, and cascade testing of at-risk family members. Moreover, these gene alterations may potentially provide novel biomarkers and therapeutic targets that are lacking in AYA patients. Among young adults with early-onset phenotypes of malignancies typically presenting at later ages, the increased prevalence of germline PV/LPVs supports a role for genetic counseling and testing irrespective of tumor type.
Keywords: Adolescents; Cancer; Predisposition genes; Young adults.
© 2022. The Author(s).
Conflict of interest statement
Angela Toss declares that she has no conflict of interest. Paola Quarello declares that she has no conflict of interest. Maurizio Mascarin has received compensation for advisory role from Merck Sharp & Dohme. Giuseppe Luigi Banna has received compensation for service as a consultant from AstraZeneca and Astellas, has received speaker’s honoraria from AstraZeneca and Astellas, and has received reimbursement for travel/accommodations from AstraZeneca. Marco Zecca declares that he has no conflict of interest. Saverio Cinieri declares that she has no conflict of interest. Fedro Alessandro Peccatori declares that he has no conflict of interest. Andrea Ferrari declares that he has no conflict of interest.
Figures
Similar articles
-
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.Eur J Cancer. 2018 May;95:20-29. doi: 10.1016/j.ejca.2018.02.028. Epub 2018 Mar 31. Eur J Cancer. 2018. PMID: 29614442 Free PMC article.
-
Characteristics of Cancers in Adolescents and Young Adults Compared with Those in Adults in Their 60s: A Single-Center Experience.Oncology. 2022;100(3):140-147. doi: 10.1159/000520291. Epub 2022 Jan 31. Oncology. 2022. PMID: 35100598
-
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.Prostate. 2021 May;81(7):427-432. doi: 10.1002/pros.24120. Epub 2021 Mar 24. Prostate. 2021. PMID: 33760238
-
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults.Cancers (Basel). 2021 Nov 5;13(21):5552. doi: 10.3390/cancers13215552. Cancers (Basel). 2021. PMID: 34771713 Free PMC article. Review.
-
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer.Curr Oncol Rep. 2021 Jan 15;23(2):17. doi: 10.1007/s11912-020-01011-9. Curr Oncol Rep. 2021. PMID: 33449203 Review.
Cited by
-
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities.J Natl Cancer Inst. 2024 Sep 1;116(9):1417-1428. doi: 10.1093/jnci/djae119. J Natl Cancer Inst. 2024. PMID: 38833671 Free PMC article.
-
Cancer Burden in Adolescents and Young Adults in Belgium: Trends to Incidence Stabilisation in Recent Years with Improved Survival.Cancers (Basel). 2025 May 1;17(9):1543. doi: 10.3390/cancers17091543. Cancers (Basel). 2025. PMID: 40361468 Free PMC article.
-
Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma.J Pers Med. 2024 Jan 23;14(2):128. doi: 10.3390/jpm14020128. J Pers Med. 2024. PMID: 38392562 Free PMC article.
-
The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma.Front Oncol. 2022 Jul 4;12:893206. doi: 10.3389/fonc.2022.893206. eCollection 2022. Front Oncol. 2022. PMID: 35860547 Free PMC article.
-
Application of Multigene Panels Testing for Hereditary Cancer Syndromes.Biology (Basel). 2022 Oct 5;11(10):1461. doi: 10.3390/biology11101461. Biology (Basel). 2022. PMID: 36290365 Free PMC article.
References
-
- In: Closing the Gap: Research and care imperatives for adolescents and young adults with cancer. https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf. Accessed 27 Sep 2021.
-
- Ferrari A, Stark D, Peccatori FA, Fern L, Laurence V, Gaspar N, et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) ESMO Open. 2021;6(2):100096. doi: 10.1016/j.esmoop.2021.100096. - DOI - PMC - PubMed
-
- Tricoli JV, Blair DG, Anders CK, Bleyer WA, Boardman LA, Khan J, et al. Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer. 2016;122(7):1017–1028. doi: 10.1002/cncr.29871. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials